1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Liu, G. Eletsky, A. Atreya, H.S. Aramini, J.M. Xiao, R. Acton, T. Montelione, G.T. Szyperski, T. Northeast Structural Genomics Consortium (NESG) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE J.STRUCT.FUNCT.GENOM. 1345-711X 10 127 136 10.1007/s10969-008-9054-7 19101823 NMR and X-RAY structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1-UBA5-UFC1 ubiquination pathway. 2009 10.2210/pdb2k07/pdb pdb_00002k07 20557.549 Ufm1-conjugating enzyme 1 1 man polymer Ubiquitin-fold modifier-conjugating enzyme 1 no no MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ HKEKCNQLEHHHHHH MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ HKEKCNQLEHHHHHH A HR41 polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample UFC1 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21(DE3) Plasmid pET21 Northeast Structural Genomics Consortium NESG PSI, Protein Structure Initiative database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Database references Derived calculations 1 0 2008-02-19 1 1 2011-07-13 1 2 2022-03-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details 2008-02-19 SPRSDE Y BMRB Y RCSB 2008-01-25 REL REL target function 100 20 2D 1H-15N HSQC SIMULTANEOUS HETERONUCLEAR RESOLVED [1H,1H]-NOESY GFT (4,3)D HNNCABCA GFT (4,3)D CABCA(CO)NHN GFT (4,3)D HABCAB(CO)NHN GFT (4,3) HCCH 1.1 mM [U-100% 13C; U-100% 15N] na 6.5 ambient 298 K molecular dynamics, simulated annealing, distance geometry, torsion angle dynamics 1 lowest energy 1.1 mM [U-100% 13C; U-100% 15N] protein UFC1, 95% H2O/5% D2O 95% H2O/5% D2O Brunger, Adams, Clore, Gros, Nilges and Read refinement CNS 1.1 Guntert, Mumenthaler and Wuthrich refinement CYANA 2.1 Guntert, Mumenthaler and Wuthrich structure solution CYANA 2.1 Guntert, Mumenthaler and Wuthrich data analysis CYANA 2.1 Huang, Tejero, Powers and Montelione data analysis AutoStructure 2.2.1 Huang, Tejero, Powers and Montelione peak picking AutoStructure 2.2.1 Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign 2.1 Zimmerman, Moseley, Kulikowski and Montelione data analysis AutoAssign 2.1 Bartels et al. chemical shift assignment XEASY 1.3.1.3 Bartels et al. data analysis XEASY 1.3.1.3 Bartels et al. peak picking XEASY 1.3.1.3 Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe 2.3 Varian collection VNMR 750 Varian INOVA Varian INOVA 600 Varian INOVA Varian INOVA MET 1 n 1 MET 1 A ALA 2 n 2 ALA 2 A ASP 3 n 3 ASP 3 A GLU 4 n 4 GLU 4 A ALA 5 n 5 ALA 5 A THR 6 n 6 THR 6 A ARG 7 n 7 ARG 7 A ARG 8 n 8 ARG 8 A VAL 9 n 9 VAL 9 A VAL 10 n 10 VAL 10 A SER 11 n 11 SER 11 A GLU 12 n 12 GLU 12 A ILE 13 n 13 ILE 13 A PRO 14 n 14 PRO 14 A VAL 15 n 15 VAL 15 A LEU 16 n 16 LEU 16 A LYS 17 n 17 LYS 17 A THR 18 n 18 THR 18 A ASN 19 n 19 ASN 19 A ALA 20 n 20 ALA 20 A GLY 21 n 21 GLY 21 A PRO 22 n 22 PRO 22 A ARG 23 n 23 ARG 23 A ASP 24 n 24 ASP 24 A ARG 25 n 25 ARG 25 A GLU 26 n 26 GLU 26 A LEU 27 n 27 LEU 27 A TRP 28 n 28 TRP 28 A VAL 29 n 29 VAL 29 A GLN 30 n 30 GLN 30 A ARG 31 n 31 ARG 31 A LEU 32 n 32 LEU 32 A LYS 33 n 33 LYS 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A TYR 36 n 36 TYR 36 A GLN 37 n 37 GLN 37 A SER 38 n 38 SER 38 A LEU 39 n 39 LEU 39 A ILE 40 n 40 ILE 40 A ARG 41 n 41 ARG 41 A TYR 42 n 42 TYR 42 A VAL 43 n 43 VAL 43 A GLU 44 n 44 GLU 44 A ASN 45 n 45 ASN 45 A ASN 46 n 46 ASN 46 A LYS 47 n 47 LYS 47 A ASN 48 n 48 ASN 48 A ALA 49 n 49 ALA 49 A ASP 50 n 50 ASP 50 A ASN 51 n 51 ASN 51 A ASP 52 n 52 ASP 52 A TRP 53 n 53 TRP 53 A PHE 54 n 54 PHE 54 A ARG 55 n 55 ARG 55 A LEU 56 n 56 LEU 56 A GLU 57 n 57 GLU 57 A SER 58 n 58 SER 58 A ASN 59 n 59 ASN 59 A LYS 60 n 60 LYS 60 A GLU 61 n 61 GLU 61 A GLY 62 n 62 GLY 62 A THR 63 n 63 THR 63 A ARG 64 n 64 ARG 64 A TRP 65 n 65 TRP 65 A PHE 66 n 66 PHE 66 A GLY 67 n 67 GLY 67 A LYS 68 n 68 LYS 68 A CYS 69 n 69 CYS 69 A TRP 70 n 70 TRP 70 A TYR 71 n 71 TYR 71 A ILE 72 n 72 ILE 72 A HIS 73 n 73 HIS 73 A ASP 74 n 74 ASP 74 A LEU 75 n 75 LEU 75 A LEU 76 n 76 LEU 76 A LYS 77 n 77 LYS 77 A TYR 78 n 78 TYR 78 A GLU 79 n 79 GLU 79 A PHE 80 n 80 PHE 80 A ASP 81 n 81 ASP 81 A ILE 82 n 82 ILE 82 A GLU 83 n 83 GLU 83 A PHE 84 n 84 PHE 84 A ASP 85 n 85 ASP 85 A ILE 86 n 86 ILE 86 A PRO 87 n 87 PRO 87 A ILE 88 n 88 ILE 88 A THR 89 n 89 THR 89 A TYR 90 n 90 TYR 90 A PRO 91 n 91 PRO 91 A THR 92 n 92 THR 92 A THR 93 n 93 THR 93 A ALA 94 n 94 ALA 94 A PRO 95 n 95 PRO 95 A GLU 96 n 96 GLU 96 A ILE 97 n 97 ILE 97 A ALA 98 n 98 ALA 98 A VAL 99 n 99 VAL 99 A PRO 100 n 100 PRO 100 A GLU 101 n 101 GLU 101 A LEU 102 n 102 LEU 102 A ASP 103 n 103 ASP 103 A GLY 104 n 104 GLY 104 A LYS 105 n 105 LYS 105 A THR 106 n 106 THR 106 A ALA 107 n 107 ALA 107 A LYS 108 n 108 LYS 108 A MET 109 n 109 MET 109 A TYR 110 n 110 TYR 110 A ARG 111 n 111 ARG 111 A GLY 112 n 112 GLY 112 A GLY 113 n 113 GLY 113 A LYS 114 n 114 LYS 114 A ILE 115 n 115 ILE 115 A CYS 116 n 116 CYS 116 A LEU 117 n 117 LEU 117 A THR 118 n 118 THR 118 A ASP 119 n 119 ASP 119 A HIS 120 n 120 HIS 120 A PHE 121 n 121 PHE 121 A LYS 122 n 122 LYS 122 A PRO 123 n 123 PRO 123 A LEU 124 n 124 LEU 124 A TRP 125 n 125 TRP 125 A ALA 126 n 126 ALA 126 A ARG 127 n 127 ARG 127 A ASN 128 n 128 ASN 128 A VAL 129 n 129 VAL 129 A PRO 130 n 130 PRO 130 A LYS 131 n 131 LYS 131 A PHE 132 n 132 PHE 132 A GLY 133 n 133 GLY 133 A LEU 134 n 134 LEU 134 A ALA 135 n 135 ALA 135 A HIS 136 n 136 HIS 136 A LEU 137 n 137 LEU 137 A MET 138 n 138 MET 138 A ALA 139 n 139 ALA 139 A LEU 140 n 140 LEU 140 A GLY 141 n 141 GLY 141 A LEU 142 n 142 LEU 142 A GLY 143 n 143 GLY 143 A PRO 144 n 144 PRO 144 A TRP 145 n 145 TRP 145 A LEU 146 n 146 LEU 146 A ALA 147 n 147 ALA 147 A VAL 148 n 148 VAL 148 A GLU 149 n 149 GLU 149 A ILE 150 n 150 ILE 150 A PRO 151 n 151 PRO 151 A ASP 152 n 152 ASP 152 A LEU 153 n 153 LEU 153 A ILE 154 n 154 ILE 154 A GLN 155 n 155 GLN 155 A LYS 156 n 156 LYS 156 A GLY 157 n 157 GLY 157 A VAL 158 n 158 VAL 158 A ILE 159 n 159 ILE 159 A GLN 160 n 160 GLN 160 A HIS 161 n 161 HIS 161 A LYS 162 n 162 LYS 162 A GLU 163 n 163 GLU 163 A LYS 164 n 164 LYS 164 A CYS 165 n 165 CYS 165 A ASN 166 n 166 ASN 166 A GLN 167 n 167 GLN 167 A LEU 168 n 168 LEU 168 A GLU 169 n 169 GLU 169 A HIS 170 n 170 HIS 170 A HIS 171 n 171 HIS 171 A HIS 172 n 172 HIS 172 A HIS 173 n 173 HIS 173 A HIS 174 n 174 HIS 174 A HIS 175 n 175 HIS 175 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLU 57 A N GLU 57 A O PHE 66 A O PHE 66 A N CYS 69 A N CYS 69 A O PHE 80 A O PHE 80 1 A A HZ1 OE1 LYS GLU 164 169 1.60 2 A A OE1 HZ2 GLU LYS 96 114 1.60 2 A A OD2 HZ2 ASP LYS 152 156 1.60 3 A A HB2 HB2 TRP PHE 65 84 1.31 4 A A OD1 HZ3 ASP LYS 85 114 1.56 4 A A HZ1 OE2 LYS GLU 17 34 1.57 6 A A HB2 HB2 TRP PHE 65 84 1.34 7 A A HZ2 OD1 LYS ASP 47 52 1.58 7 A A HZ1 OE1 LYS GLU 17 34 1.60 9 A A OE2 HZ2 GLU LYS 96 114 1.60 11 A A OD2 HZ3 ASP LYS 74 164 1.55 14 A A HD22 HB3 LEU GLU 16 35 1.33 15 A A HB2 HD3 GLU LYS 96 114 1.30 16 A A OE1 HE2 GLU HIS 79 161 1.60 17 A A OE2 HG GLU CYS 163 165 1.55 17 A A HZ2 OE1 LYS GLU 162 163 1.59 20 A A HZ2 OE2 LYS GLU 77 79 1.57 1 A ALA 2 -102.73 -161.02 1 A ASN 19 46.25 81.13 1 A TRP 53 -104.94 -68.69 1 A ASP 74 68.30 -85.95 1 A PRO 130 -96.72 -120.08 1 A HIS 161 -152.24 41.41 1 A CYS 165 -137.82 -43.23 1 A ASN 166 59.68 95.04 1 A GLN 167 72.49 -29.98 1 A LEU 168 -60.61 -71.00 1 A GLU 169 -84.76 -75.31 1 A HIS 172 -64.68 93.61 1 A HIS 173 -172.65 99.07 2 A PRO 14 -45.52 151.20 2 A LEU 75 72.65 -38.64 2 A THR 89 -83.19 40.50 2 A ILE 97 65.95 116.24 2 A LYS 108 -96.19 35.81 2 A PRO 130 -89.05 -153.33 2 A HIS 161 -67.44 95.78 3 A ASP 3 58.40 73.16 3 A LEU 75 75.36 -20.03 3 A ASP 103 -50.86 109.64 3 A LYS 108 75.31 -29.56 3 A PRO 130 -93.36 -152.88 3 A LYS 131 77.21 -5.96 4 A LEU 75 70.11 -0.60 4 A ARG 111 -156.49 82.18 4 A PRO 130 -90.43 -147.55 4 A LYS 162 -135.96 -158.05 5 A ALA 20 -140.45 -65.50 5 A ASN 51 -118.39 72.96 5 A ARG 111 -66.60 84.14 5 A PRO 130 -89.98 -158.25 5 A CYS 165 55.13 87.03 6 A TRP 53 -88.79 -78.78 6 A LEU 75 71.92 -4.89 6 A PRO 130 -84.29 -159.47 6 A LYS 162 -102.25 -71.56 6 A LYS 164 -99.97 -79.01 7 A ALA 2 -118.30 -156.00 7 A PRO 22 -69.29 2.39 7 A PHE 66 -152.36 86.06 7 A LEU 75 74.46 -33.43 7 A TYR 110 64.17 95.55 7 A PRO 130 -95.98 -154.70 7 A CYS 165 -95.39 50.74 7 A GLN 167 -178.90 135.91 8 A ALA 107 -66.99 -154.80 8 A GLN 160 -59.88 105.10 8 A GLU 163 61.88 60.95 8 A CYS 165 59.61 102.14 8 A ASN 166 -102.62 -62.93 9 A VAL 99 63.52 86.58 9 A LYS 108 -166.15 -168.49 9 A MET 109 69.51 100.10 9 A ASN 128 -105.16 70.53 9 A PRO 130 -87.92 -139.83 9 A LYS 131 75.54 -7.62 9 A GLU 163 67.62 89.67 9 A GLN 167 -59.40 100.54 9 A HIS 171 -35.98 108.83 9 A HIS 172 -136.69 -37.27 10 A ALA 2 147.03 -20.20 10 A TRP 53 -143.33 -0.25 10 A PRO 130 -77.61 -164.65 10 A LYS 131 73.66 -9.87 10 A GLU 163 -50.50 109.08 10 A GLN 167 -80.56 49.44 11 A ALA 20 -136.08 -58.08 11 A ALA 98 -96.98 -78.00 11 A VAL 99 51.69 75.79 11 A ALA 107 71.70 -35.23 11 A PRO 130 -81.92 -132.45 11 A LYS 131 70.34 -45.00 11 A GLN 167 -69.83 90.27 12 A LEU 75 75.40 -6.95 12 A ALA 98 -95.38 -62.72 12 A VAL 99 60.39 83.15 12 A ASP 103 -59.89 92.62 12 A ALA 107 -160.47 -164.08 12 A PRO 130 -86.35 -158.30 12 A LYS 131 75.77 -0.55 12 A HIS 161 -171.80 127.51 13 A ASP 3 52.09 79.46 13 A ASN 51 -114.08 76.62 13 A LEU 75 71.84 -3.75 13 A ASP 103 -69.29 89.32 13 A ALA 107 -170.70 -168.13 13 A MET 109 65.63 98.69 13 A ARG 111 -120.01 -81.50 13 A PRO 130 -81.48 -152.38 13 A LYS 131 76.02 -20.67 13 A CYS 165 61.85 86.20 14 A ASP 74 67.65 -85.80 14 A ARG 111 50.32 16.02 14 A LEU 117 -81.90 -82.20 14 A PRO 130 -95.60 -146.19 15 A THR 18 -68.32 97.17 15 A ALA 20 -146.97 -37.39 15 A ASP 74 48.08 74.07 15 A LEU 75 72.65 -33.52 15 A PRO 130 -85.03 -149.64 15 A LYS 164 -126.82 -76.10 16 A PRO 14 -49.30 151.99 16 A THR 18 -66.13 -74.80 16 A ALA 20 -81.59 -84.49 16 A ASP 74 66.83 62.93 16 A LEU 75 68.57 -13.12 16 A ASP 103 -58.75 106.39 16 A TYR 110 -109.22 -72.99 16 A PRO 130 -79.12 -163.07 16 A LYS 131 72.81 -18.53 17 A ASP 3 70.34 135.15 17 A ASN 51 -112.87 60.15 17 A LEU 117 -77.65 -80.40 17 A PRO 130 -97.11 -142.25 17 A GLN 160 75.32 80.26 17 A LYS 162 179.47 162.50 18 A PRO 14 -49.99 151.22 18 A ALA 20 -159.07 -55.17 18 A ASP 74 64.44 -85.02 18 A ALA 98 -92.62 -74.81 18 A VAL 99 61.49 82.38 18 A ARG 111 72.38 -50.18 18 A PRO 130 -86.51 -146.61 18 A LYS 131 72.89 -37.61 18 A GLU 149 -141.81 11.16 18 A LYS 162 -77.21 -82.41 18 A CYS 165 70.13 -13.21 19 A ALA 2 -89.83 40.55 19 A LEU 75 73.34 -22.46 19 A THR 106 -108.27 -164.74 19 A ASN 166 -75.85 29.25 20 A PRO 22 -67.15 3.32 20 A ASP 74 64.53 -85.95 20 A LYS 105 -133.85 -38.00 20 A ALA 107 -74.10 -154.32 20 A ARG 111 -51.85 109.47 20 A PRO 130 -88.59 -151.64 20 A LYS 131 75.24 36.66 20 A CYS 165 -68.72 95.55 Solution NMR structure of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1). Northeast Structural Genomics Consortium target HR41 1 N N A ASP 3 A ASP 3 HELX_P A GLU 12 A GLU 12 1 1 10 A ASP 24 A ASP 24 HELX_P A ALA 49 A ALA 49 1 2 26 A HIS 120 A HIS 120 HELX_P A VAL 129 A VAL 129 1 3 10 A GLY 133 A GLY 133 HELX_P A GLY 141 A GLY 141 1 4 9 A GLY 141 A GLY 141 HELX_P A LYS 156 A LYS 156 1 5 16 STRUCTURAL GENOMICS, UNKNOWN FUNCTION Ufc1, Ubiquitin Conjugating Enzyme, E2, Ufm1, Polymorphism, Ubl conjugation pathway, Structural Genomics, PSI-2, Protein Structure Initiative, Northeast Structural Genomics Consortium, NESG, UNKNOWN FUNCTION A TYR 90 A TYR 90 1 A PRO 91 A PRO 91 3.72 A VAL 129 A VAL 129 1 A PRO 130 A PRO 130 2.67 A TYR 90 A TYR 90 2 A PRO 91 A PRO 91 -2.23 A VAL 129 A VAL 129 2 A PRO 130 A PRO 130 1.02 A TYR 90 A TYR 90 3 A PRO 91 A PRO 91 0.16 A VAL 129 A VAL 129 3 A PRO 130 A PRO 130 2.21 A TYR 90 A TYR 90 4 A PRO 91 A PRO 91 -1.25 A VAL 129 A VAL 129 4 A PRO 130 A PRO 130 5.78 A TYR 90 A TYR 90 5 A PRO 91 A PRO 91 2.13 A VAL 129 A VAL 129 5 A PRO 130 A PRO 130 -0.20 A TYR 90 A TYR 90 6 A PRO 91 A PRO 91 1.12 A VAL 129 A VAL 129 6 A PRO 130 A PRO 130 6.49 A TYR 90 A TYR 90 7 A PRO 91 A PRO 91 0.59 A VAL 129 A VAL 129 7 A PRO 130 A PRO 130 1.87 A TYR 90 A TYR 90 8 A PRO 91 A PRO 91 -0.13 A VAL 129 A VAL 129 8 A PRO 130 A PRO 130 3.88 A TYR 90 A TYR 90 9 A PRO 91 A PRO 91 1.53 A VAL 129 A VAL 129 9 A PRO 130 A PRO 130 1.03 A TYR 90 A TYR 90 10 A PRO 91 A PRO 91 -2.68 A VAL 129 A VAL 129 10 A PRO 130 A PRO 130 7.17 A TYR 90 A TYR 90 11 A PRO 91 A PRO 91 1.06 A VAL 129 A VAL 129 11 A PRO 130 A PRO 130 4.14 A TYR 90 A TYR 90 12 A PRO 91 A PRO 91 0.37 A VAL 129 A VAL 129 12 A PRO 130 A PRO 130 0.19 A TYR 90 A TYR 90 13 A PRO 91 A PRO 91 -0.10 A VAL 129 A VAL 129 13 A PRO 130 A PRO 130 3.11 A TYR 90 A TYR 90 14 A PRO 91 A PRO 91 -1.33 A VAL 129 A VAL 129 14 A PRO 130 A PRO 130 5.13 A TYR 90 A TYR 90 15 A PRO 91 A PRO 91 1.83 A VAL 129 A VAL 129 15 A PRO 130 A PRO 130 1.69 A TYR 90 A TYR 90 16 A PRO 91 A PRO 91 0.64 A VAL 129 A VAL 129 16 A PRO 130 A PRO 130 2.09 A TYR 90 A TYR 90 17 A PRO 91 A PRO 91 2.71 A VAL 129 A VAL 129 17 A PRO 130 A PRO 130 4.53 A TYR 90 A TYR 90 18 A PRO 91 A PRO 91 -1.13 A VAL 129 A VAL 129 18 A PRO 130 A PRO 130 5.87 A TYR 90 A TYR 90 19 A PRO 91 A PRO 91 2.54 A VAL 129 A VAL 129 19 A PRO 130 A PRO 130 4.23 A TYR 90 A TYR 90 20 A PRO 91 A PRO 91 1.15 A VAL 129 A VAL 129 20 A PRO 130 A PRO 130 6.45 UFC1_HUMAN UNP 1 1 Q9Y3C8 MADEATRRVVSEIPVLKTNAGPRDRELWVQRLKEEYQSLIRYVENNKNADNDWFRLESNKEGTRWFGKCWYIHDLLKYEF DIEFDIPITYPTTAPEIAVPELDGKTAKMYRGGKICLTDHFKPLWARNVPKFGLAHLMALGLGPWLAVEIPDLIQKGVIQ HKEKCNQ 1 167 2K07 1 167 Q9Y3C8 A 1 1 167 1 expression tag LEU 168 2K07 A Q9Y3C8 UNP 168 1 expression tag GLU 169 2K07 A Q9Y3C8 UNP 169 1 expression tag HIS 170 2K07 A Q9Y3C8 UNP 170 1 expression tag HIS 171 2K07 A Q9Y3C8 UNP 171 1 expression tag HIS 172 2K07 A Q9Y3C8 UNP 172 1 expression tag HIS 173 2K07 A Q9Y3C8 UNP 173 1 expression tag HIS 174 2K07 A Q9Y3C8 UNP 174 1 expression tag HIS 175 2K07 A Q9Y3C8 UNP 175 3 anti-parallel anti-parallel A PHE 54 A PHE 54 A SER 58 A SER 58 A ARG 64 A ARG 64 A HIS 73 A HIS 73 A LEU 76 A LEU 76 A ASP 85 A ASP 85